体重指数正常的非酒精性脂肪性肝病的自然史:基于人群的研究
该研究基于美国Olmsted县1996至2016年诊断为NAFLD的4834例成人,按诊断时BMI分为正常、超重和肥胖三组,比较肝硬化、失代偿、恶性肿瘤、心血管事件及死亡的风险。结果显示正常BMI组代谢合并症较少,肝硬化风险有非显著下降趋势,心血管事件和恶性肿瘤风险与肥胖组相似,但全因死亡风险更高。
要点
- 正常BMI的NAFLD患者代谢合并症较少,女性比例更高。
- 正常BMI组肝硬化风险较肥胖组有非显著下降趋势(HR 0.33,95%CI 0.1-1.05)。
- 正常BMI组全因死亡风险显著高于肥胖组(HR 1.96,95%CI 1.52-2.51)。
核心结论
- 正常BMI的NAFLD与更健康的代谢特征相关,肝病进展风险可能较低,但心血管疾病和恶性肿瘤风险与肥胖NAFLD相似,且全因死亡风险更高。
研究设计与样本
- 基于美国Olmsted县1996至2016年诊断为NAFLD的4834例成人进行回顾性队列研究,按诊断时BMI分为正常(414例)、超重(1189例)和肥胖(3231例)三组。
主要发现
- 正常BMI组女性占66%,肥胖组女性占47%。
- 以肥胖组为参照,正常BMI组肝硬化风险HR为0.33(95%CI 0.1-1.05),无统计学显著性。
- 正常BMI组与肥胖组在失代偿(HR 0.79,95%CI 0.11-5.79)、心血管事件(HR 1.05,95%CI 0.73-1.51)和恶性肿瘤(HR 0.87,95%CI 0.51-1.48)风险上无显著差异。
- 正常BMI组全因死亡风险高于肥胖组(HR 1.96,95%CI 1.52-2.51)。
临床怎么用
- 对于正常BMI的NAFLD患者,应关注其较高的全因死亡风险,并评估心血管疾病和恶性肿瘤风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The natural history of lean nonalcoholic fatty liver disease (NAFLD) is not well-understood. Consequently, patient counseling and disease management are limited. We aimed to compare the natural history of lean, overweight, and obese NAFLD in a U.S. population with long-term follow-up. METHODS: All adults diagnosed with NAFLD in Olmsted County, MN between 1996 and 2016 were identified, and all subsequent medical events were ascertained using a medical record linkage system. Subjects were divided on the basis of body mass index (BMI) at NAFLD diagnosis into 3 groups: normal, overweight, and obese. The probability to develop cirrhosis, decompensation, malignancies, cardiovascular events, or death among the 3 groups was estimated by using the Aalen-Johansen method, treating death as a competing risk. The impact of BMI categories on these outcomes was explored by using Cox proportional hazards regression analysis. RESULTS: A total of 4834 NAFLD individuals were identified: 414 normal BMI, 1189 overweight, and 3231 obese. Normal BMI NAFLD individuals were characterized by a higher proportion of women (66% vs 47%) and lower prevalence of metabolic comorbidities than the other 2 groups. In reference to obese, those with normal BMI NAFLD had a nonsignificant trend toward lower risk of cirrhosis (hazard ratio [HR], 0.33, 95% confidence interval [CI], 0.1-1.05). There were no significant differences in the risk of decompensation (HR, 0.79; 95% CI, 0.11-5.79), cardiovascular events (HR, 1.05; 95% CI, 0.73-1.51), or malignancy (HR, 0.87; 95% CI, 0.51-1.48). Compared with obese, normal BMI NAFLD had higher risk of all-cause mortality (HR, 1.96; 95% CI, 1.52-2.51). CONCLUSIONS: NAFLD with normal BMI is associated with a healthier metabolic profile and possibly a lower risk of liver disease progression but similar risk of cardiovascular disease and malignancy than obese NAFLD.
引用
- Ahmed OT, Gidener T, Mara KC, et al. Natural History of Nonalcoholic Fatty Liver Disease With Normal Body Mass Index: A Population-Based Study. Clin Gastroenterol Hepatol. 2021. PMID: 34265444. doi:10.1016/j.cgh.2021.07.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。